Biomarkers of systemic inflammation in pathogenesis of syntropic occupational bronchial asthma and metabolic syndrome

In search of inflammatory molecular markers helpful in detection of increased risk and prognosis of severity of syntropic occupational bronchial asthma and metabolic syndrome, the authors conducted a study covering 140 examinees with confirmed occupational bronchial asthma. According to IDF criteria (2005), the patients were assigned into a group with combined occupational bronchial asthma and metabolic syndrome, and a group of occupational bronchial asthma without metabolic syndrome. All the examinees underwent studies of inflammation markers - biochemical (C-reactive protein, leptine) and molecular-genetic ( polymorphism of Gln223Arg gene of leptine receptor (LEPR), polymorphism of C174G gene of interleukin-6 (IL-6), polymorphism of G308A gene of (TNF-а) tumor necrosis factor alpha). Evidences are that the patients with combined bronchial asthma and metabolic syndrome demonstrate higher activity of inflammatory processes (higher level of C-reactive protein, leptine) - that manifests in clinically more severe course of bronchopulmonary disease. Moleculary-genetic markers revealed are associated with higher activity of inflammation and therefore with increased risk of occupational bronchial asthma associated with metabolic syndrome and diabetess mellitus 2 type (polymorphisms of LEPR gene, IL-6 gene).

профессиональная бронхиальная астма, метаболический синдром, воспаление, биомаркеры, С-реактивный белок, лептин, интерлейкин-6, occupational bronchial asthma, metabolic syndrome, inflammation, biomarkers, C-reactive protein, leptine, interleukin-6

1. Астафьева Н.Г., Гамова И.В., Удовиченко Е.Н. и др. // Леч. врач. - 2014. - №5. - С. 100-107.

2. Корытина Г.Ф., Целоусова О.С., Ахмадишина Л.З. и др. // Мед. генетика. - 2008. - Т. 2. - С. 17-25.

3. Урясьев О.М., Панфилов Ю.А. // Междунар. эндокринологич. ж-л. - 2008. - № 3 (15). - С. 15-25.

4. Цибулькина В.Н., Цибулькин Н.А. // Практич. мед. Акушерство. Гинекология. Эндокринология. - 2011. - № 6 (54). - С. 36-41.

5. Чернявская Г.М. // Клинич. мед. - 2003. - № 3. - С. 23-25.

6. Яковлева О.Я., Жамба А.О., Мазур Ю.В. // Рациональная фармакотерапия. - 2008. - № 1 (06). - С. 64-67.

7. De Rosa V., Procaccini C., Cali G. et al. // Immunity. - 2007. - Vol. 26. - №2. - P. 241-255.

8. Itoch M., Suganami T., Hachiya R. et al. // Int. J. Inflam. - 2011. - V. 2011. - P. 1-8.

9. Popa C., Netea M.G., Riel P. et al. // J Lipid Res. - 2007. - Vol. 48. - P. 751-762.

10. Steensberg A. // Exerc Immunol Rev. - 2003. - Vol. 9. - P. 40-47.

11. Trauhurn P., Wood I.S. // Biochem. Soc. Trans. - 2005. - № 23. - Р. 1078-1081.